retatrutide side effects long-term Retatrutide injectable weight loss medication benefits and side effects What side effects are reported

The North American GLP-1 Agonists Market Holds A Significant Revenue Share In The Region

The risk increases when GLP-1 drugs are combined with insulin or sulfonylureas, which is why dose adjustments are necessary in combination therapy

Its approved for treating type 2 diabetes and for losing weight in eligible adults

Weekly injectable semaglutideis expected to be available in Singapore in 2026, and the prices of are not fixed yet

The presence of GLP-1 receptor agonists in these products increased the risk of gastrointestinal complications, ileus, bowel obstruction, and NAION, but the manufacturers knew that such information would discourage consumers from buying and withholding this information